CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation

The in vivo administration of certain monoclonal antibodies (mAbs) against the adhesion receptor, CD44, into normal mice induces both a modulation of CD44 from the surface of peripheral lymphocytes, and a concomitant increase in the amount of soluble CD44 in the serum. CD44- negative lymphocytes isolated from anti-CD44-treated mice exhibit normal homing patterns upon adoptive transfer, and are capable of reexpressing CD44 upon activation. The treatment of haptensensitized mice with anti-CD44 mAb inhibits their ability to mount a cutaneous delayed-type hypersensitivity (DTH) response within the first 24 h after hapten challenge. This inhibition reflects a block in both the edema and leukocyte infiltration of the cutaneous site of DTH, whereas the extravasation and accumulation of leukocytes in the draining lymph nodes progress normally. After 72 h, the leukocytes that extravasate into the site of antigen challenge express CD44. These results indicate that CD44 is not necessary for normal leukocyte circulation but is required for leukocyte extravasation into an inflammatory site involving nonlymphoid tissue.

[1]  P. Herrlich,et al.  Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44 , 1993, The Journal of experimental medicine.

[2]  P. Herrlich,et al.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.

[3]  D. Tarin,et al.  Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.

[4]  V. Hořejší,et al.  Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. , 1992, Journal of immunology.

[5]  P. Herrlich,et al.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44. , 1992, Science.

[6]  Kendall A. Smith,et al.  Rational Immunotherapy with Interleukin 2 , 1992, Bio/Technology.

[7]  Q. He,et al.  Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody , 1992, The Journal of experimental medicine.

[8]  E. Puré,et al.  Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages , 1991, The Journal of cell biology.

[9]  T. Aune,et al.  Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. , 1991, Journal of immunology.

[10]  I. Stamenkovic,et al.  Distinct effects of two CD44 isoforms on tumor growth in vivo , 1991, The Journal of experimental medicine.

[11]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[12]  W. Carter,et al.  Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons , 1991, The Journal of cell biology.

[13]  M. Amiot,et al.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.

[14]  E. Butcher,et al.  The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513] , 1990, The Journal of cell biology.

[15]  D. S. Webb,et al.  LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. , 1990, Science.

[16]  K. Miyake,et al.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.

[17]  L. Davis,et al.  Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. , 1990, Journal of immunology.

[18]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[19]  J. August,et al.  Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. , 1990, Journal of immunology.

[20]  K. Miyake,et al.  Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long- term bone marrow cultures , 1990, The Journal of experimental medicine.

[21]  L. Wahl,et al.  Dual role of the CD44 molecule in T cell adhesion and activation. , 1989, Journal of immunology.

[22]  E. Puré,et al.  Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Caillou,et al.  CD44 contributes to T cell activation. , 1989, Journal of immunology.

[24]  E. Berg,et al.  The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes , 1989, Nature.

[25]  D. Evered,et al.  The biology of hyaluronan. , 1989, Ciba Foundation symposium.

[26]  H. Kolb,et al.  IL-1 and IFN-gamma increase vascular permeability. , 1988, Immunology.

[27]  J. M. Stoltz,et al.  Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma. , 1988, Journal of immunology.

[28]  E. Butcher,et al.  Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. , 1988, Journal of immunology.

[29]  Eugene C. Butcher,et al.  A tissue-specific endothelial cell molecule involved in lymphocyte homing , 1988, Nature.

[30]  R. Fernandez-Botran,et al.  Epitopes on CD45R [T200] molecules define differentiation antigens on murine B and T lymphocytes. , 1988, The Journal of molecular and cellular immunology : JMCI.

[31]  B. E. Lacy,et al.  The hyaluronate receptor is associated with actin filaments , 1987, The Journal of cell biology.

[32]  J. R. de los Toyos,et al.  Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells , 1987, The Journal of cell biology.

[33]  H. Macdonald,et al.  Selectively increased production of interferon-gamma by subsets of Lyt-2+ and L3T4+ T cells identified by expression of Pgp-1. , 1987, Journal of immunology.

[34]  J. Bluestone,et al.  Identification of a monoclonal antibody specific for a murine T3 polypeptide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Jalkanen,et al.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man , 1986, European journal of immunology.

[36]  F. Takei Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). , 1985, Journal of immunology.

[37]  I. Weissman,et al.  A cell-surface molecule involved in organ-specific homing of lymphocytes , 1983, Nature.

[38]  B. Haynes,et al.  Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. , 1983, The Journal of clinical investigation.

[39]  K. A. Wall,et al.  Cloned T Lymphocytes and Monoclonal Antibodies as Probes for Cell Surface Molecules Active in T Cell‐Mediated Cytolysis , 1982, Immunological reviews.

[40]  M. Seman,et al.  Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. , 1982, Journal of immunology.

[41]  G. Mengod,et al.  Murine cell surface glycoproteins. Characterization of a major component of 80,000 daltons as a polymorphic differentiation antigen of mesenchymal cells. , 1981, The Journal of biological chemistry.

[42]  Q. Myrvik,et al.  Participation of hyaluronic acid in the macrophage disappearance reaction. , 1980, Immunological communications.

[43]  B. Ridell,et al.  The cellular infiltrate in contact hypersensitivity to picryl chloride in the mouse. , 1979, Acta dermato-venereologica.

[44]  G. Galfré,et al.  Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens , 1978, European journal of immunology.

[45]  P. Phanuphak,et al.  Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. , 1974, Journal of immunology.

[46]  K. Landsteiner,et al.  Experiments on Transfer of Cutaneous Sensitivity to Simple Compounds , 1942 .